Risk factors for cytomegalovirus infection after human marrow transplantation
- PMID: 3005424
- DOI: 10.1093/infdis/153.3.478
Risk factors for cytomegalovirus infection after human marrow transplantation
Abstract
The records of 545 patients were reviewed for risk factors associated with cytomegalovirus (CMV) infection after marrow transplant. CMV infection occurred among 36% of seronegative patients and 69% of seropositive patients. Among seronegative patients, significant risk factors for CMV infection included positive serology of the marrow donor (relative rate, 2.3) and the use of granulocyte transfusions from seropositive donors (relative rate, 2.5). Among both seronegative and seropositive patients, the occurrence of acute graft-versus-host disease (GVHD) significantly increased the risk of CMV infection (average relative rate, 1.8) and of subsequent CMV pneumonia (average relative rate, 2.6). CMV excretion and viremia were each associated with subsequent pneumonia, but the positive predictive values were low. One-third of long-term survivors excreted CMV at greater than 250 days after transplantation. The only risk factor for late excretion was CMV infection that occurred in the first 150 days after transplantation. In contrast to the effect of acute GVHD on CMV infection, CMV infection did not increase the risk of either acute or chronic GVHD.
Similar articles
-
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.Bone Marrow Transplant. 1990 Jun;5(6):413-8. Bone Marrow Transplant. 1990. PMID: 2164434
-
Cytomegalovirus infection after marrow transplantation for aplastic anemia.Bone Marrow Transplant. 1990 Nov;6(5):295-300. Bone Marrow Transplant. 1990. PMID: 1963336 Clinical Trial.
-
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.Bone Marrow Transplant. 1993 Sep;12(3):283-8. Bone Marrow Transplant. 1993. PMID: 8241988 Clinical Trial.
-
Cytomegalovirus infection after bone marrow transplantation in children.Hum Immunol. 2004 May;65(5):416-22. doi: 10.1016/j.humimm.2004.02.013. Hum Immunol. 2004. PMID: 15172440 Review.
-
Early and late interstitial pneumonia following human bone marrow transplantation.Int J Cell Cloning. 1986;4 Suppl 1:107-21. doi: 10.1002/stem.5530040712. Int J Cell Cloning. 1986. PMID: 3018098 Review.
Cited by
-
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential.Front Immunol. 2012 Aug 14;3:259. doi: 10.3389/fimmu.2012.00259. eCollection 2012. Front Immunol. 2012. PMID: 22912640 Free PMC article.
-
Prevention and treatment of CMV infection after allogeneic bone marrow transplant.Ann Hematol. 1992 Jun;64 Suppl:A158-61. doi: 10.1007/BF01715372. Ann Hematol. 1992. PMID: 1322189
-
Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.J Virol. 2003 Dec;77(24):13301-14. doi: 10.1128/jvi.77.24.13301-13314.2003. J Virol. 2003. PMID: 14645586 Free PMC article.
-
Human Cytomegalovirus (HCMV) - Revised.Transfus Med Hemother. 2010;37(6):365-375. doi: 10.1159/000322141. Epub 2010 Nov 17. Transfus Med Hemother. 2010. PMID: 21483467 Free PMC article. No abstract available.
-
Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):53-7. Clin Exp Immunol. 1994. PMID: 8033436 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
